Home
Browse All Titles
Sign In
Browse All Titles
Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
◀
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
▶
View All
Fab
FcR
Fc receptor (FcR)
FDR
fixed dose rate (FDR)
FK-binding proteins (FKBPs)
FKBPs
Flu
fludarabine, cyclophosphamide, rituximab (FCR)
Question 11.5
Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase
Question 3.1
fludarabine (Flu)
FMS-like tyrosine kinase 3 (FLT3)
Folates
Folic acid
cycle, conversion of dUMP to dTMP
cell physiology
role in metabolism
folylpolyglutamyl synthetase (FPGS)
Food and Drug Administration (FDA)
Basic Drug Development With Structural Considerations
Immunotherapeutics Including Vaccines, Bispecifics, CAR-T, and Checkpoint Inhibitors
Question 18.1
Anticancer Drug Development: An Introduction
Drug Approval and Regulatory Issues
Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
Targeted Therapies (Small Molecules)
F-PG
FR
fragment crystallizable (Fc)
Fc
FCR
FDA
FdUMP
FK-506 binding proteins (FKBP)
FKBP
FLT3
fluorodeoxyuridine monophosphate (FdUMP)
folate receptor (FR)
FPGS
fragment antigen-binding (Fab)
Refresh
first
prev
1
30
select
next
last
Displaying items 1 - 29 of 29